HealthQuill Lymph Nodes
The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to treat people with a type of breast cancer that has worsened after at least one hormone treatment.The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to treat people with a type of breast cancer that has worsened after at least one hormone treatment.
Drugs Health Pharma

FDA clears Eli Lilly’s combination drug for metastatic breast cancer

HQ Team September 21, 2026: The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to.

Read More
AstraZeneca’s mantle cell lymphoma combination rug, Calquence, reduced the risk of disease progression or death by up to 27%, according to a company statement.
Drugs Health Pharma

AstraZeneca’s trial drug for mantle cell lymphoma raises survival rate

AstraZeneca’s mantle cell lymphoma combination rug, Calquence, reduced the risk of disease progression or death by up to 27%, according to a company.

Read More